HomeAI · summaries
Storia in 5 fonti
GSK lays out plans to cut costs, pursue more late-stage drug trials
New GSK CEO Luke Miels outlined his strategy to help the company navigate a patent cliff and get on a path toward long-term growth.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
GSK prepares for patent cliff with $2.5B cost-cutting plan
The pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss of patents important to its HIV drug franchise.
- ·
cityam.com
Sweeping job cuts at GSK to fund £400m Cambridge campus
GSK is poised to slash its back office headcount to help fund a £400m mega-campus in Cambridge in a move aimed a bolstering its pipeline.
